المؤلفون: Iyer SG, Stanchina M, Bradley TJ, Watts J

المصدر: Cancer Management and Research, Vol Volume 14, Pp 2267-2272 (2022)

مصطلحات موضوعية: acute myeloid leukemia, glasdegib, lower intensity induction, hedgehog signaling pathway, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.dovepress.com/profile-of-glasdegib-for-the-treatment-of-newly-diagnosed-acute-myeloi-peer-reviewed-fulltext-article-CMAR; https://doaj.org/toc/1179-1322

URL الوصول: https://doaj.org/article/915fe6b329a24a8da4ece28708dbe157

المؤلفون: Tay, CW, Shen, L, Hartman, M, Iyer, SG, Madhavan, K, Chang, SK

المصدر: Minimally invasive surgery. 2013:381628

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:223766898

المؤلفون: Guan Huei Lee, Muthiah, Daniel Q. Huang, Quek Wl, Iyer Sg, Chahed H, Tan Exx, Chen M, Suryadi, Chew Ly, Raj P, Tan Ek, Cheng S, James Fung, Albert C. Y. Chan, Hoe J

المصدر: SSRN Electronic Journal.

مصطلحات موضوعية: medicine.medical_specialty, Deceased donor, Coronavirus disease 2019 (COVID-19), business.industry, medicine.medical_treatment, Incidence (epidemiology), Liver failure, Liver transplantation, medicine.disease, Living donor, Internal medicine, Hepatocellular carcinoma, Overall survival, Medicine, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::dfb4c0ae4806e05e4984a7f32be9408d
https://doi.org/10.2139/ssrn.3847737

المؤلفون: Arora, P, Tarneja, P, Iyer, SG, Duggal, BS, Sharma, RK

المصدر: In Medical Journal Armed Forces India 2002 58(4):319-322

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Patel AA; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL., Yoon JJ; Division of Hematologic Malignancies, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA., Johnston H; Department of Medicine, Internal Medicine Residency, University of Chicago, Chicago, IL., Davidson MB; Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Shallis RM; Department of Internal Medicine, Section of Hematology, Yale School of Medicine and Yale Cancer Center, New Haven, CT., Chen EC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Burkart M; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC., Oh TS; Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL., Iyer SG; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY., Madarang E; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL., Muthiah C; Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, WI., Gross I; University of Chicago Comprehensive Cancer Center, Chicago, IL., Dean R; University of Chicago Comprehensive Cancer Center, Chicago, IL., Kassner J; Memorial Sloan Kettering Cancer Center, New York, NY., Viswabandya A; Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Madero-Marroquin R; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL., Rampal RK; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Guru Murthy GS; Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI., Bradley T; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL., Abaza Y; Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL., Garcia JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Gupta V; Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Pettit KM; Division of Hematology and Medical Oncology, Department of Internal Medicine, University of Michigan Medical School, Michigan Medicine, Ann Arbor, MI., Cursio JF; Department of Public Health Sciences, University of Chicago, Chicago, IL., Odenike O; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL.

المصدر: Blood advances [Blood Adv] 2024 Jul 09; Vol. 8 (13), pp. 3468-3477.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Myeloproliferative Disorders*/therapy , Myeloproliferative Disorders*/mortality , Myeloproliferative Disorders*/drug therapy, Humans ; Female ; Middle Aged ; Male ; Aged ; Adult ; Treatment Outcome ; Hematopoietic Stem Cell Transplantation ; Aged, 80 and over ; Blast Crisis/therapy ; Blast Crisis/mortality ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use